Chemerin was not changed in the 15 type 2 diabetic HCC patients and the 6 CRC patients when both cohorts were analyzed separately (p = 0.25 for HCC and p = 0.47 for CRC patients). The gene discussed is RARRES2; the disease is hepatocellular carcinoma.